Published in J Clin Microbiol on December 01, 1984
Antifungal susceptibility testing. Clin Microbiol Rev (1993) 9.04
Collaborative investigation of variables in susceptibility testing of yeasts. Antimicrob Agents Chemother (1990) 8.42
Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods. Antimicrob Agents Chemother (1987) 7.33
New and emerging yeast pathogens. Clin Microbiol Rev (1995) 4.75
Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. J Clin Microbiol (1990) 2.99
Emergence of a new opportunistic pathogen, Candida lusitaniae. J Clin Microbiol (1989) 2.63
International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia. Eur J Clin Microbiol Infect Dis (2005) 2.34
Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome. J Clin Microbiol (1996) 2.19
Candida infections of the genitourinary tract. Clin Microbiol Rev (2010) 1.90
Rationale for selective use of anaerobic blood cultures. J Clin Microbiol (1993) 1.77
Strain delineation and epidemiology of Candida (Clavispora) lusitaniae. J Clin Microbiol (1992) 1.66
In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods. J Clin Microbiol (2009) 1.60
Rapid identification of Candida species by DNA fingerprinting with PCR. J Clin Microbiol (1996) 1.52
Patterns of amphotericin B killing kinetics against seven Candida species. Antimicrob Agents Chemother (2004) 1.50
Rapid susceptibility testing of fungi by flow cytometry using vital staining. J Clin Microbiol (1997) 1.42
Evaluation of Abbott Quantum II yeast identification system. J Clin Microbiol (1985) 1.30
Disruption of ergosterol biosynthesis confers resistance to amphotericin B in Candida lusitaniae. Antimicrob Agents Chemother (2003) 1.26
Epidemiology of nosocomial acquisition of Candida lusitaniae. J Clin Microbiol (1992) 1.21
Identification of Candida species by randomly amplified polymorphic DNA fingerprinting of colony lysates. J Clin Microbiol (1997) 1.21
Rapid susceptibility testing of Candida albicans by flow cytometry. J Clin Microbiol (1997) 1.19
Alternative identification test relying upon sexual reproductive abilities of Candida lusitaniae strains isolated from hospitalized patients. J Clin Microbiol (2001) 1.11
Change in colony morphology of Candida lusitaniae in association with development of amphotericin B resistance. Antimicrob Agents Chemother (2002) 1.05
Comparison of four DNA-based methods for strain delineation of Candida lusitaniae. J Clin Microbiol (1995) 1.02
Inactivation of the FCY2 gene encoding purine-cytosine permease promotes cross-resistance to flucytosine and fluconazole in Candida lusitaniae. Antimicrob Agents Chemother (2005) 1.02
High-frequency, in vitro reversible switching of Candida lusitaniae clinical isolates from amphotericin B susceptibility to resistance. Antimicrob Agents Chemother (1999) 1.01
Flucytosine-fluconazole cross-resistance in purine-cytosine permease-deficient Candida lusitaniae clinical isolates: indirect evidence of a fluconazole uptake transporter. Antimicrob Agents Chemother (2003) 0.97
Phenotypic switching in Candida lusitaniae on copper sulfate indicator agar: association with amphotericin B resistance and filamentation. J Clin Microbiol (2006) 0.94
Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in Candida lusitaniae. PLoS One (2012) 0.91
Phenotypic Switching in Fungi. Curr Fungal Infect Rep (2008) 0.87
The Candida pathogenic species complex. Cold Spring Harb Perspect Med (2014) 0.86
Antifungal susceptibility testing of fluconazole by flow cytometry correlates with clinical outcome. J Clin Microbiol (2001) 0.82
Antigenic and phenotypic variations in fungi. Cell Microbiol (2009) 0.82
Activities of D0870, a novel triazole, against Candida lusitaniae and Trichosporon beigelii in experimental murine infections. Antimicrob Agents Chemother (1995) 0.82
Candida lusitaniae causing fatal meningitis. Postgrad Med J (1993) 0.75
Ocellatin peptides from the skin secretion of the South American frog Leptodactylus labyrinthicus (Leptodactylidae): characterization, antimicrobial activities and membrane interactions. J Venom Anim Toxins Incl Trop Dis (2017) 0.75
Deletion of the uracil permease gene confers cross-resistance to 5-fluorouracil and azoles in Candida lusitaniae and highlights antagonistic interaction between fluorinated nucleotides and fluconazole. Antimicrob Agents Chemother (2014) 0.75
New challenges to the therapy of systemic fungal infections. Trans Am Clin Climatol Assoc (1996) 0.75
Incidence of polyene-resistant yeasts recovered from clinical specimens. Antimicrob Agents Chemother (1980) 4.53
Development of resistance to amphotericin B in Candida lusitaniae infecting a human. Antimicrob Agents Chemother (1979) 3.79
Identification of Candida lusitaniae as an opportunistic yeast in humans. J Clin Microbiol (1979) 3.30
Fatal septicemia due to amphotericin B-resistant Candida lusitaniae. J Clin Microbiol (1983) 2.34
Isolation and characterization of a polyene-resistant variant of Candida tropicalis. J Clin Microbiol (1979) 2.03
Characterization of atypical Candida tropicalis and other uncommon clinical yeast isolates. J Clin Microbiol (1982) 1.59
Candida lusitaniae: a new opportunistic pathogen of the urinary tract. Diagn Microbiol Infect Dis (1984) 1.34
Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med (1991) 12.09
Detection of amphotericin B-resistant Candida isolates in a broth-based system. Antimicrob Agents Chemother (1995) 4.92
Incidence of polyene-resistant yeasts recovered from clinical specimens. Antimicrob Agents Chemother (1980) 4.53
Detection of circulating candida enolase by immunoassay in patients with cancer and invasive candidiasis. N Engl J Med (1991) 4.20
Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrob Agents Chemother (1993) 3.25
Detection of surgical pathogens by in vitro DNA amplification. Part I. Rapid identification of Candida albicans by in vitro amplification of a fungus-specific gene. Surgery (1990) 2.93
Candida tropicalis: a major pathogen in immunocompromised patients. Ann Intern Med (1979) 2.71
Association of electrophoretic karyotype of Candida stellatoidea with virulence for mice. Infect Immun (1988) 2.13
The value of fungal surveillance cultures as predictors of systemic fungal infections. J Infect Dis (1980) 2.10
Isolation and characterization of a polyene-resistant variant of Candida tropicalis. J Clin Microbiol (1979) 2.03
Identification of Candida dubliniensis in a prospective study of patients in the United States. J Clin Microbiol (1999) 2.02
Fatal disseminated candidiasis due to amphotericin-B-resistant Candida guilliermondii. Ann Intern Med (1985) 1.84
Increased incidence of fungemia caused by Candida krusei. J Clin Microbiol (1986) 1.82
Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1987) 1.82
Colonization and infection with Trichosporon species in the immunosuppressed host. J Infect Dis (1983) 1.69
Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg (2001) 1.63
Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients. J Infect Dis (1996) 1.58
Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens. Antimicrob Agents Chemother (1993) 1.54
Novel method for processing respiratory specimens for detection of mycobacteria by using C18-carboxypropylbetaine: blinded study. J Clin Microbiol (1998) 1.48
Comparison of an automated repetitive sequence-based PCR microbial typing system to pulsed-field gel electrophoresis for analysis of outbreaks of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2005) 1.46
Infections due to Xylohypha bantiana (Cladosporium trichoides). Rev Infect Dis (1989) 1.45
Electrophoretic karyotypes of Torulopsis glabrata. J Clin Microbiol (1989) 1.45
Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals. J Clin Microbiol (2000) 1.44
Disseminated infection with Trichosporon beigelii. Rev Infect Dis (1988) 1.40
Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology. Clin Infect Dis (1997) 1.38
Favorable outcome of invasive aspergillosis in patients with acute leukemia. J Clin Oncol (1987) 1.37
Pathogenicity of Candida tropicalis and Candida albicans after gastrointestinal inoculation in mice. Infect Immun (1980) 1.34
Oral Candida dubliniensis as a clinically important species in HIV-seropositive patients in the United States. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1999) 1.30
Evaluation of a reformulated CHROMagar Candida. J Clin Microbiol (2001) 1.29
Molecular mycology: DNA probes and applications of PCR technology. J Med Vet Mycol (1994) 1.29
Coaggregation of Candida dubliniensis with Fusobacterium nucleatum. J Clin Microbiol (1999) 1.28
Opportunistic mycotic osteomyelitis: bone infections due to Aspergillus and Candida species. Medicine (Baltimore) (1977) 1.27
Evaluation of two commercially prepared biphasic media for recovery of fungi from blood. J Clin Microbiol (1978) 1.26
Differences in virulence of clinical isolates of Candida tropicalis and Candida albicans in mice. Infect Immun (1982) 1.23
Pathologic features in the human alimentary tract associated with invasiveness of Candida tropicalis. Am J Clin Pathol (1986) 1.15
Resistance to amphotericin B: emerging clinical and microbiological patterns. Drug Resist Updat (1998) 1.14
Nocardia asteroides keratitis. Br J Ophthalmol (1979) 1.12
Infection in a neonate caused by Pichia fabianii: importance of molecular identification. Med Mycol (2006) 1.11
Laboratory evaluation of serological tests for systemic candidiasis: a cooperative study. J Clin Microbiol (1977) 1.10
Clinical evaluation of the addition of gentamicin to commercially prepared mycological media. J Clin Microbiol (1976) 1.08
Recovery of Candida dubliniensis and other yeasts from human immunodeficiency virus-associated periodontal lesions. J Clin Microbiol (2001) 1.08
A phaeohyphomycotic cyst and peritonitis caused by Phialemonium species and a reevaluation of its taxonomy. J Clin Microbiol (1993) 1.08
Candida dubliniensis and Candida albicans display surface variations consistent with observed intergeneric coaggregation. Rev Iberoam Micol (1999) 1.07
Diagnosis and therapeutic monitoring of invasive candidiasis by rapid enzymatic detection of serum D-arabinitol. Am J Med (1995) 1.06
Media with pH indicators for the isolation of dermatophytes. Arch Dermatol (1970) 1.06
Improved recovery of group A beta-hemolytic streptococci with a new selective medium. J Clin Microbiol (1985) 1.04
The molecular analysis of synonymy among medically important yeasts within the genus Candida. J Gen Microbiol (1992) 1.03
Experimental central nervous system phaeohyphomycosis following intranasal inoculation of Xylohypha bantiana in cortisone-treated mice. Mycopathologia (1987) 1.02
Comparison of four DNA-based methods for strain delineation of Candida lusitaniae. J Clin Microbiol (1995) 1.02
Susceptibility testing of filamentous fungi to amphotericin B by a rapid radiometric method. J Clin Microbiol (1984) 1.02
Two rapid pigmentation tests for identification of Cryptococcus neoformans. J Clin Microbiol (1982) 1.01
Recurrent Francisella philomiragia sepsis in chronic granulomatous disease. Pediatr Infect Dis J (1998) 1.01
Invasive aspergillosis. N Engl J Med (1976) 1.01
Methicillin-resistant Staphylococcus caprae in a neonatal intensive care unit. J Clin Microbiol (2005) 1.00
Response to empiric amphotericin B during antileukemic therapy-induced granulocytopenia. Rev Infect Dis (1991) 0.98
Paecilomyces lilacinus fungemia in an adult bone marrow transplant recipient. Med Mycol (1999) 0.98
Evaluation of antibody coating of yeasts in urine as an indicator of the site of urinary tract infection. J Clin Microbiol (1975) 0.97
Aspergillus infections in bone marrow transplant recipients. Bone Marrow Transplant (1987) 0.94
Three serologic tests for candidiasis. Diagnostic value in distinguishing deep or disseminated infection from superficial infection or colonization. Am J Clin Pathol (1976) 0.93
Refinements of environmental assessment during an outbreak investigation of invasive aspergillosis in a leukemia and bone marrow transplant unit. Infect Control Hosp Epidemiol (2000) 0.91
Surveillance strategies and impact of vancomycin-resistant enterococcal colonization and infection in critically ill patients. Ann Surg (2001) 0.90
A case of cutaneous ulcerative alternariosis: rare association with diabetes mellitus and unusual failure of itraconazole treatment. Clin Infect Dis (2001) 0.90
Mucocutaneous candidiasis in a mother and son. Arch Dermatol (1973) 0.90
Coaggregation of oral Candida isolates with bacteria from bone marrow transplant recipients. J Clin Microbiol (1990) 0.89
Granulomatous encephalitis caused by Bipolaris hawaiiensis. Arch Pathol Lab Med (1986) 0.89
Cell surface hydrophobicity-associated adherence of Candida dubliniensis to human buccal epithelial cells. Rev Iberoam Micol (2001) 0.88
Nocardia asteroides corneal ulcer. Am J Ophthalmol (1982) 0.87
Primary cutaneous phaeohyphomycosis caused by Drechslera spicifera. Arch Dermatol (1977) 0.87
Specific identification of Penicillium marneffei by a polymerase chain reaction/hybridization technique. Med Mycol (1998) 0.85
Recurrent, disseminated Mycobacterium marinum infection caused by the same genotypically defined strain in an immunocompromised patient. J Clin Microbiol (1999) 0.85
Vancomycin resistance, esp, and strain relatedness: a 1-year study of enterococcal bacteremia. J Clin Microbiol (2004) 0.85
Characterization of a Trichophyton mentagrophytes and its diffusible pigment. Sabouraudia (1972) 0.84
An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis. Am J Med (1988) 0.83
Primary cutaneous aspergillosis. J Am Acad Dermatol (1980) 0.83
Prevention of fungal sepsis in patients with prolonged neutropenia: a randomized, double-blind, placebo-controlled trial of intravenous miconazole. Am J Med (1987) 0.82
Association of reduced total iron binding capacity and fungal infections in leukemic granulocytopenic patients. J Clin Oncol (1986) 0.82
Aspergillus osteomyelitis in an immunocompetent adolescent: a case report and review of the literature. Pediatrics (1982) 0.81
In vitro evaluation of MR hypointensity in Aspergillus colonies. AJNR Am J Neuroradiol (1994) 0.80
Pulmonary, cardiac, and thyroid involvement in disseminated Pseudallescheria boydii. Arch Pathol Lab Med (1984) 0.80
Primary cutaneous Aspergillus nidulans infection associated with a Hickman catheter in a patient with neutropenia. Clin Infect Dis (1999) 0.80
Allescheria boydii mycetoma complicating pulmonary sarcoid. Johns Hopkins Med J (1974) 0.79
Developments in the diagnostic mycology laboratory. J Med Vet Mycol (1992) 0.77
Prevalence of yeast among children in Nigeria and the United States. Oral Microbiol Immunol (2001) 0.77
Otitis caused by Scedosporium apiospermum in an immunocompetent child. Int J Pediatr Otorhinolaryngol (2004) 0.77
Strategies to prevent or control infections after bone marrow transplants. Bone Marrow Transplant (1991) 0.77
New assay for measuring cell surface hydrophobicities of Candida dubliniensis and Candida albicans. Clin Diagn Lab Immunol (2001) 0.76
Infection management during antileukemia treatment-induced granulocytopenia: the role for oral norfloxacin prophylaxis against infections arising from the gastrointestinal tract. Scand J Infect Dis Suppl (1986) 0.76
Primary invasive cutaneous Microsporum canis infections in immunocompromised patients. J Clin Microbiol (1996) 0.76
Randomized trial of lipid-based amphotericin B for invasive aspergillosis in neutropenic hosts is an important step forward. Clin Infect Dis (1998) 0.75
Differences in the growth of Aspergillus fumigatus on cycloheximide media at three temperatures. Antimicrob Agents Chemother (1973) 0.75
Management of infections in patients with acute leukemia. Oncology (Williston Park) (2000) 0.75
Susceptibility testing of medically important fungi. Adv Exp Med Biol (1986) 0.75
Characterization and mating reactions of clinical isolates of Trychophyton mentagrophytes and T. rubrum which produce a diffusible brownish pigment. Sabouraudia (1974) 0.75
Management of infectious complications of acute leukemia and antileukemia therapy. Oncology (Williston Park) (1990) 0.75
Systemic infection and colonization with and without prophylactic norfloxacin use over time in the granulocytopenic, acute leukemia patient. Eur J Cancer Clin Oncol (1988) 0.75
Sclerotium formation in an Aspergillus flavus wound infection. Mycopathologia (1988) 0.75